The ELISA Detectability and Potency of Pegfilgrastim Decrease in Physiological Conditions: Key Roles for Aggregation and Individual Variability

PEGylated recombinant human granulocyte colony stimulating factor (pegfilgrastim) is used clinically to accelerate immune reconstitution following chemotherapy and is being pursued for biosimilar development. One challenge to overcome in pegfilgrastim biosimilar development is establishing pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Tao, Fang, Hui, Ouyang, Weiming, Angart, Phillip, Chiang, Meng-Jung, Bhirde, Ashwinkumar A., Sheikh, Faruk, Lynch, Patrick, Shah, Ankit B., Patil, Sharadrao M., Chen, Kang, Shen, Meiyu, Agarabi, Cyrus, Donnelly, Raymond P., Brorson, Kurt, Schrieber, Sarah J., Howard, Kristina E., Rogstad, Sarah M., Frucht, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016140/
https://www.ncbi.nlm.nih.gov/pubmed/32051479
http://dx.doi.org/10.1038/s41598-020-59346-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016140/
https://www.ncbi.nlm.nih.gov/pubmed/32051479
http://dx.doi.org/10.1038/s41598-020-59346-z

Ejemplares similares